Shares of Johnson Matthey PLC (LON:JMAT) have earned an average recommendation of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is GBX 4,010 ($52.40).

Several equities research analysts have issued reports on JMAT shares. UBS Group reaffirmed a “sell” rating on shares of Johnson Matthey in a research note on Thursday, July 18th. Deutsche Bank reaffirmed a “buy” rating on shares of Johnson Matthey in a research note on Thursday, July 18th. Berenberg Bank reaffirmed a “buy” rating on shares of Johnson Matthey in a research note on Tuesday, August 20th. HSBC raised their price target on shares of Johnson Matthey from GBX 3,650 ($47.69) to GBX 3,750 ($49.00) and gave the stock a “buy” rating in a research note on Wednesday, June 5th. Finally, Credit Suisse Group started coverage on shares of Johnson Matthey in a research note on Monday, September 2nd. They set an “outperform” rating and a GBX 4,200 ($54.88) price target on the stock.

In other news, insider Robert MacLeod purchased 12 shares of the firm’s stock in a transaction on Wednesday, July 17th. The shares were bought at an average cost of GBX 3,225 ($42.14) per share, with a total value of £387 ($505.68). Insiders have acquired a total of 36 shares of company stock worth $110,448 over the last ninety days.

LON:JMAT traded up GBX 66 ($0.86) during mid-day trading on Friday, hitting GBX 3,235 ($42.27). 484,523 shares of the company’s stock traded hands, compared to its average volume of 691,012. Johnson Matthey has a 1 year low of GBX 2,574 ($33.63) and a 1 year high of GBX 3,692 ($48.24). The company has a market cap of $6.26 billion and a PE ratio of 15.07. The firm’s 50 day simple moving average is GBX 2,983.14 and its 200 day simple moving average is GBX 3,160.69. The company has a debt-to-equity ratio of 50.40, a quick ratio of 0.95 and a current ratio of 1.64.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Further Reading: What is a Stop Order?

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.